Colorectal cancer population screening programs worldwide in 2016: An update

Table 2 Results of European Screening Programs

Country	Netherlands	Italy	Ireland	Lithuania	Croatia	Czech Republic	Slovenia	England	France
ASRi	40.2	33.9	34.9	23.4	32.9	39.9	37	30.2	36.1
ASRm	13.4	10.8	12.2	13.7	18.7	15.4	16.2	10.7	12.9
Period	2014-2015	2007-2009	2008-2009	2009-2012	2007-2011	2000-2011	2009-2014	2006-2010	2008-2009
Age	55-75	50-69	50-74	50-74	50-74	> 50	50-69	60-69	50-74
Test	FIT	FIT	FIT	FIT	gFOBT	gFOBT/FIT	FIT	gFOBT	gFOBT
Participation, n (%)	129395 (68.2)	81619 (54.4)	9993 (51)	271396 (46)	210239 (19.9)	521429 (22.7)	152475 (60.43)	1079293 (52)	2964976 (34.3)
M, n (%)			2126 (42)				55.23%	510864 (49.6)	32.10%
F , n (%)			2937 (42)				65.53%	568429 (54.4)	36.20%
Positive test, n (%)	15802 (12.2)	(5.8)	514 (10)	19455 (7.2)	12477 (6.9)	31794 (6.1)	8108 (5.9)	21106 (2%)	82786 (2.8)
M, n (%)	14.50%		254 (5)				7.60%	12776 (2.5)	3.30%
F, n (%)	10.10%		260 (5)				4.70%	8330 (1.5)	2.40%
Colonoscopies performed	74.30%	92.50%	87%	66.10%	66%	95.70%	98.90%	83%	88.40%
Advanced adenomas, n (%)	3832 (33.5)	702	99 (24)	3.90%	41%	3077	1887 (25.16)	1721 (9.8)	14276
PPV Advanced adenomas	NA	30.20%	5%	NA	NA	16.80%	NA	NA	19.60%
CRC, n (%)	763 (6.7)	70	38 (9)	3.10%	472 (3.6)	829	159 (2.16)	1772 (10.1)	7.50%
PPV CRC	6.70%	3%	4%	NA	NA	4.50%	NA	NA	NA
CRC detection rate per 1000	5.9	1.6	3.3	0.2	NA	1	NA	NA	1.9

NA: Not available.